TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
邵幼雲SHAO, YU-YUN
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
發表文獻
83筆
21
Huai-Hsuan Chiu, Hsiao-Wei Liao, Yu-Yun Shao, Yen-Shen Lu, Ching-Hung Lin, I-Lin Tsai, Ching-Hua Kuo. Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS. Analytica Chimica Acta 2018 Aug; 1019: 93-102#
22
Tsung-Hao Liu, Chih-Hung Hsu, Yu-Yun Shao. Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure. Liver Cancer 2018 May; 7: 205-208 (corresponding author)#
23
Yi-Hsin Liang, Yu-Yun Shao, Ho-Min Chen, Ann-Lii Cheng, Mei-Shu Lai, Kun-Huei Yeh. Irinotecan and Oxaliplatin Might Provide Equal Benefit as Adjuvant Chemotherapy for Patients with Resectable Synchronous Colon Cancer and Liver-confined Metastases: A Nationwide Database Study. Anticancer Research 2017 Dec; 37: 7095-7104#
24
Yu-Yun Shao, Hang Lin, Yong-Shi Li, Ying-Hui Lee, Ho-Min Chen, Ann-Lii Cheng, Chih-Hung Hsu. High Plasma Interleukin-6 Levels Associated with Poor Prognosis of Patients with Advanced Hepatocellular Carcinoma. Japanese Journal of Clinical Oncology 2017 Oct; 47: 949-953#
25
Yu-Yun Shao, Min-Shu Hsieh, Han-Yu Wang, Yong-Shi Li, Hang Lin, Hung-Wei Hsu, Chung-Yi Huang, Chih-Hung Hsu, Ann-Lii Cheng. Hepatitis C Virus Core Protein Potentiates Proangiogenic Activity of Hepatocellular Carcinoma Cells. Oncotarget 2017 Sep; 8: 86681-86692#
26
Yu-Yun Shao, Bang-Bin Chen, Da-Liang Ou, Zhong-Zhe Lin, Chih-Hung Hsu, Miao-Jen Wang; Ann-Lii Cheng, Chiun Hsu. Lenalidomide as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Exploration of Biomarkers for Treatment Efficacy. Alimentary Pharmacology & Therapeutics 2017 Oct; 46: 722-730#
27
Wen-Ying Lin, Chih-Peng Lin, Chih-Hung Hsu, Ying-Hui Lee, Yi-Ting Lin, Meng-Chi Hsu, Yu-Yun Shao. Right or Left? Side Selection for a Totally Implantable Vascular Access Device: A Randomized Observational Study. British Journal of Cancer 2017 Sep; 117: 932-937 (Corresponding author)#
28
Wen-Chi Shen, Jen-Shi Chen, Yu-Yun Shao, Kuan-Der Lee, Tzeon-Jye Chiou, Yung-Chuan Sung, Kun-Ming Rau, Chia-Jui Yen, Yu-Min Liao, Ta-Chih Liu, Ming-Fang Wu, Ming-Yang Lee, Ming-Sun Yu, Wen-Li Hwang, Pang-Yu Lai, Cheng-Shyong Chang, Wen-Chi Chou, and Ruey-Kuen Hsieh. Impact of Undertreatment of Cancer Pain with Analgesic Drugs on Patient Outcomes: A Nationwide Survey of Outpatient Cancer Patient Care in Taiwan. Journal of Pain and Symptom Management 2017 Jul;54: 55-65#
29
Yu-Yun Shao,* Emily Han-Chung Hsiue,* Chih-Hung Hsu, Chien-An Yao, Ho-Min Chen, Mei-Shu Lai, Ann-Lii Cheng. National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer Patients. The Oncologist 2017 Jul;22:843–849# (*co-first authors)
30
Li-Chun Lu, Pei-Jer Chen, Yi-Chun Yeh, Chih-Hung Hsu, Ho-Min Chen, Mei-Shu Lai, Yu-Yun Shao, and Ann-Lii Cheng. Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study. Anticancer Research 2017 May; 37: 2593-2599# (Corresponding author)
